跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pfizer (Australia) METHOTREXATE 50mg/2mL injection BP - TGA Drug Approval Details
Approvals
/
TGA
/
Pfizer (Australia) METHOTREXATE 50mg/2mL injection BP
Approved
STANDARD
Pfizer (Australia) METHOTREXATE 50mg/2mL injection BP
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
1d3104f4d8c20c68
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
1d3104f4d8c20c68
Product Name
Pfizer (Australia) METHOTREXATE 50mg/2mL injection BP
Artg Id
10777
Artg Name
Pfizer (Australia) METHOTREXATE 50mg/2mL injection BP
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1991-07-09
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/58a1d8a725fde6a7f077efc0dc7112a3.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
1d3104f4d8c20c68
Type
Standard
Back to TGA Approvals